Gosta Labs, a Helsinki-based HealthTech firm innovating within the oncology sector, has closed a €7.5 million Seed spherical to scale its AI working system for advanced medical specialties.
The spherical was led by Voima Ventures, with participation from COR Group, the Aho household, and each current and new traders, together with Reaktor and a gaggle of notable angel traders. This follows a €1.7 million pre-Seed spherical in 2024 and brings the corporate’s whole funding to just about €10 million.
“We began Gosta Labs to deliver AI to help extraordinarily advanced medical specialties like oncology, to provide care groups again time and headspace for his or her sufferers by taking over the documentation work that drains their day,” says Lauri Sippola, CEO and co-founder of Gosta Labs.
In 2025, a number of European HealthTech startups working in oncology and adjoining medical AI fields have secured notable funding rounds – offering sector context for Gosta Labs’ increase.
Swiss-based CGC Genomics raised €1.7 million to advance its regulated GenAI platform for deciphering most cancers genome information. London’s Perci Well being secured €4 million to scale its AI-driven digital most cancers clinic. Barcelona-based Sycai Medical obtained €3 million to additional develop its AI medical system for early most cancers detection, whereas Leiden’s BIMINI Biotech raised €3 million to progress its haematological most cancers therapeutics.
On this context, Gosta Labs’ Seed spherical represents one of many bigger early-stage financings within the oncology-AI phase this 12 months, contributing to a sector whole of roughly €11.7 million in comparable 2025 funding bulletins.
Gosta’s Finland headquarters additionally stands out, as Finland doesn’t seem among the many different 2025 oncology-AI fundings, underscoring its relative place within the area.
“This funding helps us deliver our trusted AI assistant to oncology groups world wide and deepen our medical system grade product and AI basis, so each affected person encounter could be safer, extra private, and fewer burdened by administration,” provides Sippola.
Based in 2023 by Lauri Sippola and Henri Viertolahti, who beforehand based Kaiku Well being (acquired by Elekta in 2020), Gosta Labs is growing an AI working system for advanced medical specialties, like oncology, enabling extra environment friendly, exact, and personalised care throughout all the affected person journey. Gosta Labs presently companions with healthcare suppliers in Finland, Switzerland, the Baltics, and Australia.
The corporate’s staff combines AI scientists with skilled oncology and MedTech leaders, together with Chief Medical Officer Dr Lionel Hadjadjeba and Chief Working Officer Reetta Arokoski.
“This know-how is already reshaping our medical workflows. The power to provide structured, correct notes immediately and classify key medical parameters mechanically frees oncologists to spend their time the place it issues most – with their sufferers. In observe, this has already reduce documentation time by over two-thirds for every affected person go to at our most cancers centre,” says Dr Razvan Popescu, Medical Director at Tumor Heart Aargau and the lead investigator within the research.
Most cancers care is changing into more and more advanced.
As per information offered by the corporate – by 2050, greater than 35 million new most cancers instances are anticipated to be recognized throughout over 100 several types of most cancers. In the meantime, Gosta Labs highlights that clinicians spend a number of hours a day on administrative work inside fragmented programs and unstructured medical information, whereas multidisciplinary groups should make quick, high-stakes selections concerning an ever-growing variety of personalised remedy choices.
Gosta Labs goals to handle these challenges with an oncology-focused AI working system that transforms each affected person go to into high-quality structured information in actual time.
The system summarises and visualises affected person journeys, automates medical documentation, and captures structured medical information related to affected person care. It additionally reportedly improves high quality of care by assessing key medical parameters for every remedy pathway and mechanically linking selections to worldwide pointers.
“Gosta Labs’ key staff members mix confirmed startup execution, deep area experience and high notch AI capabilities. They’ve accomplished it earlier than and know what attractiveness like, which is a vital for any startup staff,” mentioned Jussi Sainiemi, Associate at Voima Ventures. “There’s a whole lot of hype round AI however Gosta delivers the worth it guarantees and clients love the product.”
The primary real-world outcomes from the Gosta AI Working System had been introduced on the ESMO 2025 Congress, a world oncology convention.
Outcomes counsel that the oncology-focused system generates high-quality oncology session notes in actual time, structured in keeping with institutional requirements. It additionally mechanically classifies Efficiency Standing and CTCAE toxicity grades.
Oncologists had been reportedly in a position to full follow-up go to documentation in a median time of below two minutes, lowering their documentation burden and enabling them to spend extra time with sufferers.
